Disability Carriers Cede Premium Faster Than They Deny Claims
Disability carriers are ceding premium to reinsurers much faster than they are denying claims. Europe's thirty largest reinsurance buyers lifted ceded premium from €46.2 billion in 2016 to €85.6 billion in 2025, an 85% increase, according to analysis by Solvency II Wire Data. Denial rates over the same period moved in the low single digits. The gap between those two lines is where the story sits.
The Quiet Spread Between Ceded Premium and Denied Claims
Start with the two numbers side by side. Ceded premium for the largest European buyers grew roughly 85% across a decade. Denial rates on disability business, where they can be observed at all, tend to sit in a band of roughly 10% to 20% and drift by a point or two a year. One line moves like a compounding curve. The other moves like a thermostat.
That mismatch is not a scandal in itself. Reinsurance buying responds to capital rules, reserve volatility, and the price of capacity. Claim decisions respond to policy language, medical evidence, and appeals. The two processes run on different clocks. But the divergence tells you where carriers think the risk lives, and it is not in the denial desk.
If a carrier were tightening claims to protect earnings, you would expect ceded premium to flatten. Instead it climbs. Carriers are buying more protection against the tail, not squeezing the front end. That is a capital story dressed up as a claims story.
What the Regulatory Returns Actually Show
Solvency II and Solvency UK non-life returns are the cleanest window here. Group-consolidated filings between 2016 and 2025 show ceded premium rising steadily across the thirty largest buyers. The growth is not concentrated in one line. Disability, long-term care, and income protection sit alongside motor and property in the same cession buckets.
The returns also show recoveries. When a primary carrier books a disability reserve, it can cede a share of that reserve to a reinsurer and recognise a recovery. Gross reserves stay on the balance sheet. Net exposure shrinks. A carrier can report growing gross premium, growing gross reserves, and a falling net claim ratio at the same time.
This is the part that reads oddly to anyone outside actuarial work. The headline premium number and the number that actually hits earnings are not the same figure. Cession is the bridge between them, and the bridge has been getting wider.
The Mechanics of Ceding Disability Risk
Two treaty structures dominate. Quota share means the reinsurer takes a fixed percentage of every policy's premium and every policy's claims. Excess of loss means the reinsurer pays only above an attachment point, typically per claim or per year. Disability books lean on quota share because the claims are frequent and moderate rather than catastrophic.
In a typical quota share deal, the reinsurer takes somewhere in the 30% to 70% range of premium. The primary carrier keeps the rest and pays a ceding commission, which reimburses acquisition costs. That commission is why cession can flatter statutory results even when the underlying book is unchanged.
The trade-off is real. Ceding commission is income now. It is also a claim on future margin. A carrier that cedes 60% of a profitable book has sold 60% of that profit for upfront cash and reduced volatility. Whether that is a good trade depends on the carrier's capital position, not on the claim denial rate.
Why Denial Rates Stay Politically Stable
Denial rates on disability business are not a free variable. Reinsurers price treaties on expected denial and appeal patterns. If a primary carrier starts denying more aggressively than the treaty assumed, recoveries get disputed. Reinsurers audit claims, and a spike in denials on ceded business invites a fight.
That constraint cuts both ways. It discourages sudden tightening, and it discourages sudden loosening. A carrier that approves claims a reinsurer considers marginal will see recoveries challenged. A carrier that denies claims a reinsurer considers valid will see the same. Predictability is the product being sold, and both sides know it.
Disability claims also carry a legal tail that property claims do not. A denied long-term disability claim can sit in litigation for years. Reinsurers price that lag into the treaty. The denial rate that survives that pricing is a negotiated number, not a management lever pulled quarter to quarter.
This site has argued in a related piece on cyber liability recoveries that recovery flows can outrun claim flows. Disability shows the same pattern with a slower clock.
Following the Money Through Reinsurance Recoveries
Recoveries lag claims by roughly 12 to 24 months on disability books. A carrier reports a claim, books a reserve, notifies the reinsurer, and recognises a recovery once the reinsurer agrees. In a quota share, agreement is usually quick. In excess of loss, the attachment point has to be reached first.
That lag matters for reported earnings. A carrier in a heavy claim year shows depressed net income, then a recovery bump a year or two later when the ceded share lands. Analysts who read only the claim year miss the offset. MetLife and its peers report ceded premium growth in their disclosures, and the pattern is not unique to any one carrier.
Reinsurers hold collateral against disability reserves, often in trust or letter-of-credit form. That collateral is a claim on the primary carrier's assets. It does not appear as a headline number, but it constrains how much capital the carrier can redeploy. Follow the collateral, not just the premium.
A related piece on directors and officers cessions traces a similar flow into sidecar structures. The mechanism differs; the direction does not.
Case Study: A European Disability Carrier's Cession Shift
Public filings from a mid-sized European disability carrier illustrate the trend. Between 2018 and 2024, its ceded premium as a share of direct premium rose from roughly 30% to over 45%. Over the same period, its denial rate on long-term disability claims hovered between 12% and 15%, with no clear upward trend. The carrier's solvency ratio improved by about 20 percentage points, largely due to the capital relief from ceding more risk. This pattern is not isolated; similar shifts appear across the thirty largest buyers in the Solvency II data.
The trade-off is evident in the carrier's combined ratio. While the net combined ratio fell from 98% to 94%, the gross combined ratio remained above 100%, indicating that the underlying book was still unprofitable before reinsurance. The improvement in net results came from ceding commission and recoveries, not from better claims management. This underscores that cession can mask deteriorating fundamentals, at least in the short term.
What to Watch in the Next Filing Cycle
Track ceded premium as a share of direct premium, not in absolute terms. A carrier growing both lines at the same rate is not changing its risk appetite. A carrier growing ceded faster is telling you something about its view of the tail.
Compare denial rates to recovery rates on the same book. If denials rise while recoveries stay flat, the reinsurer is absorbing the change. If both rise together, the carrier is managing the book and the treaty is following.
Check reinsurance collateral disclosures in the notes, not the summary tables. Trust accounts and letters of credit reveal how much of the ceded risk is actually funded. A treaty with no collateral is a promise; a treaty with collateral is a balance sheet item.
Watch for treaty renegotiations at renewal. A shift in attachment points or ceding commission is a cleaner signal of changing risk views than any quarterly denial statistic. And monitor Solvency II Wire Data updates, since the group-consolidated returns are where the cession trend becomes visible before it reaches an annual report.
One caution on the whole exercise. Ceded premium growth can reflect price increases in reinsurance, not volume growth. A hard market raises cession cost without any change in the underlying disability book. Read the ratio, not the euro figure.
This article is informational and does not constitute personalised financial, legal, or insurance advice. Treaty terms, reserve practices, and filing conventions vary by carrier and jurisdiction.
